Fadogia agrestis is having a moment. Brands see the buzz and immediately think: Let's make gummies. I get it. Gummies are where the money is. But as someone who's spent years on the manufacturing floor, I can tell you that turning this West African botanical into a gummy is a lot trickier than most people expect. Know what you're getting into before you sign that contract.
The problems start with the raw material itself. Fadogia agrestis extract is a whole-plant powder, and whole-plant powders don't play nicely with gummy equipment.
The Particle Size Problem
Most Fadogia extracts come as a coarse powder. That's fine for capsules. Capsules don't care about particle size uniformity, but gummies do. When you mix that powder into a hot slurry of gelatin, sweeteners, and water, the heavy bits sink and the fine bits float. If the particles are too large, say bigger than the opening of your depositing nozzle, they clog the line or settle in the holding tank.
I've seen batches where the first gummy out of the line carried 30% more active ingredient than the last one. That is a quality failure and a regulatory nightmare waiting to happen. Your brand's reputation is on the line with every gummy.
What you can do: Specify that your Fadogia extract must be milled to at least an 80-mesh particle size. Demand a particle size distribution report on every certificate of analysis. If your contract manufacturer doesn't do in-process testing, like pulling samples every 15 minutes to check active content, find one who does.
Masking the Bitterness Without Going Broke
Fadogia agrestis is bitter. This bitterness lingers and overpowers everything else; a few drops of lemon flavor won't touch it. In a capsule, you never taste it. In a gummy, you chew it slowly. Your customers will notice.
The usual fixes, citric acid, sugar, and artificial flavors, fall flat. You can't dump in enough sugar without ruining the texture or blowing past your label claims. The heat used to cook gummy slurries also destroys most flavor systems. Masking agents you screened at room temperature break down at 80°C.
There is a workaround, but it's not cheap. You can encapsulate the Fadogia extract with a thin film coating, zein or ethylcellulose, before it ever touches the gummy mass. That creates a physical barrier between the bitter compounds and your customer's taste buds. Add your flavor system after the cooking step, during the cool-down hold, so it doesn't get cooked off. It adds cost and complexity, but it's the only way I've seen work consistently.
The Moisture Problem
Gummies are thirsty. Their water activity runs higher than a dry botanical powder, so they pull moisture from anything around them, including their own ingredients. Fadogia agrestis extract contains residual sugars and plant mucilage that act as moisture magnets. Over time, that moisture migrates into the gummy matrix and causes three problems:
- Crystallization: The gelatin network hardens. Your soft, chewy gummy turns into a hard, gritty puck.
- Microbial growth: If the water activity creeps above roughly 0.70, mold and bacteria can take hold.
- Active degradation: The compounds buyers are paying for break down in the acidic, wet environment of a gummy. Accelerated stability studies on botanical gummies often show meaningful potency loss within three months.
Desiccants and moisture-barrier bags help, but the real fix is the gummy base itself. A pectin-based gummy or a starch-gelatin hybrid offers much better moisture stability. Pectin gummies are finicky. They need a specific pH and a calcium setting system that can interact with the minerals in a botanical extract. You need a manufacturer willing to run pilot batches and tweak the formula until it works.
Gummy vs. Capsule
A lot of brands assume that if a formula works in a capsule, it'll work in a gummy. It won't. A gummy and a capsule behave differently in the body.
- Dissolution: Gummies dissolve in the mouth and stomach at variable rates depending on chew time, gummy density, and digestion. Fadogia's steroidal compounds are lipophilic and absorb better alongside fats. A gummy supplies no fat to help them.
- Heat sensitivity: Gummy production involves prolonged heat, above 80°C for extended periods. Some compounds in botanical extracts don't survive that. You need a forced degradation study before you commit to this format.
- Dose uniformity: Particle settling is a real problem. The only way to catch it is in-process testing during production. Most small manufacturers don't have that capability.
If you're set on gummies, run a pilot batch and test it under accelerated stability conditions before you commit to a full production run. You don't want to learn this lesson after the product is already on shelves.
The Regulatory Gray Zone
I'm not going to make any health claims. That's not my job. From a compliance standpoint, Fadogia agrestis sits in a gray area. It's a botanical with limited history of use in the U.S. market. The FDA requires a New Dietary Ingredient (NDI) notification for a dietary ingredient that was not marketed before October 15, 1994. If a Fadogia product has no NDI filing and the ingredient wasn't on the pre-1994 market, that's a liability for you and for your manufacturer.
We make sure our customers provide documentation that proves the ingredient's status. We also include a clear disclaimer in our contracts that regulatory compliance for the finished product is their responsibility. Don't assume your supplier has it handled. Ask to see their paperwork.
What Your Label Can and Can't Say
Fadogia sells because brands position it for male health, and that positioning is where the real liability sits. The evidence behind it rests on a single 2005 rat study by Yakubu and colleagues. No controlled human trial has measured testosterone response to Fadogia in people, and the same line of rodent work reported dose-dependent damage to testicular tissue. The human safety picture is not established.
That leaves a brand with two problems. Every label claim that hints at testosterone, vitality, or performance is a claim you would have to defend with evidence you don't have. The FDA has not reviewed Fadogia for safety or effectiveness, and testosterone-booster supplements have repeatedly been found to contain undeclared prescription medicines. The second problem is the supply itself: an analytical study of 17 supplements claiming Fadogia found the expected phenolic markers absent entirely in five of them.
None of this changes the manufacturing story, but it changes the math. When the ingredient's own evidence base is that thin, your product rests on your supplier's certificate of analysis and your own label discipline. Keep claims to structure/function language, verify every batch, and write the landing page as if a regulator will read it.
Is It Worth It?
I'm not going to tell you not to make Fadogia agrestis gummies. They can be done, and they need to be done right. The checklist I'd give any brand considering this product:
- Source a fine-milled extract (80 mesh or finer).
- Use encapsulated taste masking, not flavors alone.
- Choose a pectin or hybrid gummy base for better moisture stability.
- Run forced degradation and accelerated stability studies before scaling up.
- Require in-process active content monitoring during production.
Manufacturers who give you the cheapest quote will skip several of these steps. That's why many Fadogia gummy projects fail, either on the lab bench, in the stability chamber, or with customers who spit out the first bitter bite.
At KorNutra, we don't pretend that every ingredient is easy to work with. Fadogia agrestis gummies are technically demanding, but with the right process controls and formulation expertise, they can deliver a consistent, stable, and palatable product. If you're serious about this format, bring us your extract and your stability requirements. We'll tell you what it takes, no sugar-coating.